Unbound Supplements Byld 30 Servings
Unbound Supplements BYLD is an All New muscle building supplement that contains patented branded versions of Laxogenin, Epicatechin, and Phosphatidic Acid. This is a powerful muscle building supplement and muscle hardener, however it's non-hormonal so there's no need for post cycle support (PCT). If you're looking to get started with ProHormones and are overwhelmed or intimidated by them, BYLD is a great starter muscle building supplement, grab yourself a bottle today!
Unbound Supps BYLD Muscle Builder Product Highlights
- Muscle Hardening Muscle Building Supplement
- Straightforward 5 Ingredient Formula
- Made w/ Premium Patented Branded Ingredients
- Helps You Achieve Your Desired Physique
- Contains Laxosterone Branded Laxogenin
- Contains Proepicate Branded Epicatechin
Take 4 capsules on an empty stomach prior to training.
Unbound Supplements BYLD 30 Servings Ingredients
Serving Size: 4 Capsules
Servings Per Container: 30
Mediator 50P (std to 50% phosphatidic acid) 1500mg
Proepicate [std. to 90% epicatechin (Cocoa bean)] 300mg
Laxosterone [(5-alpha-hydroxy-laxogenin) (smilax officinalis extract) (root)] 150mg
AstraGin [Astragalus membranaceous (root) Panax notoginseng (root)] 50mg
Apigenin [Apium graveolens L. (whole plant)] 25mg
*Daily Value Not Established
Store in a cool dry place after opening.
AKAHORI A, YASUDA F. [Laxogenin, a new steroidal sapogenin isolated from Smilax sieboldi Miq]. Yakugaku Zasshi. 1963 May;83:557-8. Japanese. PMID: 14041495.
Wang Q, Xu J, Liu X, Gong W, Zhang C. Synthesis of brassinosteroids analogues from laxogenin and their plant growth promotion. Nat Prod Res. 2015;29(2):149-57. doi: 10.1080/14786419.2014.968151. Epub 2014 Oct 14. PMID: 25311045.
Mafi F, Biglari S, Ghardashi Afousi A, Gaeini AA. Improvement in Skeletal Muscle Strength and Plasma Levels of Follistatin and Myostatin Induced by an 8-Week Resistance Training and Epicatechin Supplementation in Sarcopenic Older Adults. J Aging Phys Act. 2019 Jun 1;27(3):384-391. doi: 10.1123/japa.2017-0389. Epub 2019 Feb 27. PMID: 30299198.